Back to ICD-10 library
ICD-10-CM · FY 2026 APRIL UPDATE

T46.6X

Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs

Diagnosis reference

Nonbillable category

This entry is a category or subcategory. Choose the appropriate billable descendant based on the clinical documentation.

Effective periodOctober 1, 2026–September 30, 2027
SourceCMS ICD-10-CM order file
ClassificationDiagnosis · clinical modification

Related entries

Up to 30 descendants in this category

CODEDESCRIPTIONTYPE
T46.6X1Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)Category
T46.6X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounterBillable
T46.6X1DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounterBillable
T46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequelaBillable
T46.6X2Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harmCategory
T46.6X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounterBillable
T46.6X2DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounterBillable
T46.6X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequelaBillable
T46.6X3Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assaultCategory
T46.6X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounterBillable
T46.6X3DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounterBillable
T46.6X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequelaBillable
T46.6X4Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undeterminedCategory
T46.6X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounterBillable
T46.6X4DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounterBillable
T46.6X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequelaBillable
T46.6X5Adverse effect of antihyperlipidemic and antiarteriosclerotic drugsCategory
T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounterBillable
T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterBillable
T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequelaBillable
T46.6X6Underdosing of antihyperlipidemic and antiarteriosclerotic drugsCategory
T46.6X6AUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounterBillable
T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterBillable
T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequelaBillable

Use the complete reference

This reference does not reproduce the full tabular hierarchy, inclusion notes, Excludes1/2 notes, sequencing instructions, or seventh-character rules. Review the official tables and coding guidelines.

Open official CMS files

ICD-10-CM codes describe diagnoses. They do not have an independent Medicare PFS reimbursement amount, and billability alone does not establish coverage.